Marquez-Rodas I, Alvarez A, Arance A, Valduvieco I, et al. Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study). Neuro Oncol 2024 Jul 1:noae116. doi: 10.1093.
PMID: 38946469